Delivery Order SPE2DB20D2104-SPE2DB23FV16U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,124.71 to AmerisourceBergen Drug Corp for Fluorouracil 5% cream in 40-gram units, with an ultimate completion date of October 30, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,241.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fluorouracil 5% cream (40 grams) on September 16, 2025, with an ultimate completion date of September 17, 2025. The delivery order was issued without a set-aside designation, indicating open and competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the performance location for this pharmaceutical supply delivery. This delivery order...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order worth $5,426.97 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of January 29, 2024 and is a firm fixed-price arrangement. The contract supports the DLA's pharmaceutical and medical supply distribution programs, providing a wide range of products including specialty medications, brand-name and generic drugs, vaccines, syringes,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $94,252.99 delivery order is part of the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,513.12 firm fixed-price delivery order is for the supply of Fluocinonide 0.05% gel, a topical medication. The contract has an ultimate completion date of June 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of OPZELURA 1.5% CREAM 60GM pharmaceutical products. The $3,737.85 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense, with an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $43,550 to Amerisourcebergen Drug Corporation for 4561683564 Fluorouracil 5% Cream 40gm. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product to the Defense Logistics Agency by August 3, 2023 from its facility in Conshohocken, Pennsylvania. The Defense Logistics Agency supports America's armed forces by providing supplies in various categories including...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,814.34 for pharmaceutical products and medical supplies. The contract was issued by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX24FG775) valued at $3,395.24 with a period of performance ending on February 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the delivery of pharmaceutical products and medical supplies. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,951.25. The contract, awarded by the Defense Logistics Agency (DLA), is for pharmaceutical and medical supplies to support military healthcare programs. The contract is a Firm Fixed Price award and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV16UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,069.47 fixed-price delivery order is for the supply of Fluorouracil 5% Cream, a pharmaceutical product. The contract has a period of performance ending on September 5, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is likely a delivery order placed against that larger IDC. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/2/23 |